Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP134318.RARh2goh7CR0KNZyMIQtm0Hkx41X73u4135tXt4luvVUY130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134318.RARh2goh7CR0KNZyMIQtm0Hkx41X73u4135tXt4luvVUY130_provenance.
• NP150769.RATGIp9Tam_rBOMdtCPH7LuEFquT1LIADcbb2W7FWUG2o130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150769.RATGIp9Tam_rBOMdtCPH7LuEFquT1LIADcbb2W7FWUG2o130_provenance.
• NP134319.RApfyCtICQuD43bvWzQIA32yr4xlS5RM59w_G8Ii7nS9g130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134319.RApfyCtICQuD43bvWzQIA32yr4xlS5RM59w_G8Ii7nS9g130_provenance.
• assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP109300.RAfHG88OrpJfr6k5fyK2V4LPNJtGX8HwJ9GP9-Xfwmhws130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109300.RAfHG88OrpJfr6k5fyK2V4LPNJtGX8HwJ9GP9-Xfwmhws130_provenance.
• NP109303.RASQyOPacjvdmYiQIwJXvxZm511_fiyfWPAmvezJOc8us130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109303.RASQyOPacjvdmYiQIwJXvxZm511_fiyfWPAmvezJOc8us130_provenance.
• NP109301.RAqzx9O8oVZzMV-gtniqPmONi1iJlrxmwTlS8Pg8-6hNw130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109301.RAqzx9O8oVZzMV-gtniqPmONi1iJlrxmwTlS8Pg8-6hNw130_provenance.
• NP109305.RAu2JTPwJlb4A46whmgYFXtesAlyn3MZKzKvmBzbLJKPU130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109305.RAu2JTPwJlb4A46whmgYFXtesAlyn3MZKzKvmBzbLJKPU130_provenance.
• NP93885.RAPSldQ1-ZllgLMd7QLVZ91R_h2xc770OneLdWhG-lu3s130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP93885.RAPSldQ1-ZllgLMd7QLVZ91R_h2xc770OneLdWhG-lu3s130_provenance.
• NP150770.RA0xe439hQCbDon8Xi0lonElI680ukFP2mNbdgaY5PMTQ130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150770.RA0xe439hQCbDon8Xi0lonElI680ukFP2mNbdgaY5PMTQ130_provenance.
• NP150771.RAJipdmJWWH7zG_BwL9UU6fHME0LIoypjyUKthL7_Mo0g130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150771.RAJipdmJWWH7zG_BwL9UU6fHME0LIoypjyUKthL7_Mo0g130_provenance.
• NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_provenance.
• NP109306.RA4mugSF51jKpRM_Oq9E5pCfYRR76SwyJzpvkTUSM9wX8130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109306.RA4mugSF51jKpRM_Oq9E5pCfYRR76SwyJzpvkTUSM9wX8130_provenance.